...
首页> 外文期刊>Journal of Infection >Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia
【24h】

Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia

机译:审查稿件:肺炎球菌的血小板激活机制以及血小板在社区获得的肺炎中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Highlights ? The pneumococcus promotes platelet activation. ? This is achieved by various mechanisms involving bacterial adhesins, pneumolysin and possibly H 2 O 2 . ? Pneumococcal and all-cause CAP are associated with alterations in blood platelet counts, particularly thrombocytopenia. ? Altered platelet counts in CAP are predictive of a poor outcome. ? Measurement of systemic biomarkers of platelet activation in CAP may have predictive potential. Summary There is increasing recognition of the involvement of platelets in orchestrating inflammatory responses, driving the activation of neutrophils, monocytes and vascular endothelium, which, if poorly controlled, may lead to microvascular dysfunction. Importantly, hyperreactivity of platelets has been implicated in the pathogenesis of myocardial injury and the associated particularly high prevalence of acute cardiovascular events in patients with severe community-acquired pneumonia (CAP), of which Streptococcus pneumoniae (pneumococcus) is the most commonly encountered aetiologic agent. In this context, it is noteworthy that a number of studies have documented various mechanisms by which the pneumococcus may directly promote platelet aggregation and activation. The major contributors to platelet activation include several different types of pneumococcal adhesin, the pore-forming toxin, pneumolysin, and possibly pathogen-derived hydrogen peroxide, which collectively represent a major focus of the current review. This is followed by an overview of the limited experimental studies together with a larger series of clinical studies mainly focused on all-cause CAP, which have provided evidence in support of associations between alterations in circulating platelet counts, most commonly thrombocytopenia, and a poor clinical outcome. The final section of the review covers, albeit briefly, systemic biomarkers of platelet activation which may have prognostic potential.
机译:强调 ?肺炎球菌促进血小板活化。还这是通过各种涉及细菌咬合素,肺炎蛋白和可能H 2 O 2的机制来实现的。还肺炎球菌和全因帽与血小板计数,特别是血小板减少症的改变有关。还盖帽的改变血小板计数是预测差的结果。还帽中血小板激活的系统生物标志物的测量可能具有预测潜力。发明内容越来越识别血小板在协调炎症反应中的累积,驱动中性粒细胞,单核细胞和血管内皮的激活,如果控制不良,可能导致微血管功能障碍。重要的是,血小板的高反应性涉及心肌损伤的发病机制和严重社区获得的肺炎(帽)患者急性心血管事件的相关特别高的患病率,其中肺炎链球菌(肺炎球菌)是最常见的化学药剂。在这种情况下,值得注意的是,许多研究记录了肺炎球菌可直接促进血小板聚集和激活的各种机制。血小板激活的主要贡献者包括几种不同类型的肺炎球菌粘附素,孔形成毒素,肺炎肺蛋白和可能的病原体衍生的过氧化氢,其共同代表了当前审查的主要重点。随后,这是有限的实验研究的概述,以及一系列主要集中在全因盖帽的一系列临床研究中,这提供了支持循环血小板计数,最常见的血小板减少症和缺乏临床之间的改变之间的关联的证据结果。审查封面的最后一部分,尽管短暂地,血小板激活的全身生物标志物,其可能具有预后潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号